Sodium Oxybate Solution
Product Images NDC 31722-891

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sodium Oxybate (NDC 31722-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Bottle Label)

Label for Sodium Oxybate Oral Solution 0.5 g/mL by Camber Pharmaceuticals, Inc. The solution is for oral administration only, must be diluted before use, and comes in a 180 mL bottle. Manufactured by Ascent Pharmaceuticals, Inc. The label includes storage instructions, warnings, and a barcode.*

FDA Label Image

Carton Label (Carton Label)

Packaging label for Sodium Oxybate Oral Solution 0.5 g/mL by Camber Pharmaceuticals, Inc. The label indicates a 180 mL bottle with instructions to dilute before use and dispense the medication guide with each patient. The label provides NDC 31722-891-18, warnings to keep out of reach of children, and storage recommendations at 20°C to 25°C (68°F to 77°F).*

FDA Label Image

A (Figure A)

Illustration showing a bottle of sodium oxybate oral solution (0.5 g/mL), a medication guide, two labeled pharmacy containers, and a dosing syringe. Also included is a demonstration of filling a 1/4 cup with water from a tap, noting that the measuring cup and water for dilution are not provided with the sodium oxybate oral solution prescription.*

FDA Label Image

B (Figure B)

An instructional diagram showing hands opening a child-resistant safety cap on a medication bottle. The cap is labeled with 'HOLD TAB DOWN' and 'TURN,' indicating how to open it by holding down the tabs and turning the cap.*

FDA Label Image

C (Figure C)

Illustration showing the step-by-step instructions for opening a bottle of sodium oxybate oral solution. The image highlights removing the tamper evident band from the bottle cap and demonstrates the proper technique to twist open the cap securely.*

FDA Label Image

D (Figure D)

An instructional illustration showing how to properly insert a syringe into a bottle of sodium oxybate oral solution. The image displays a hand holding the bottle and another hand pushing the syringe down. Two close-up insets indicate incorrect and correct syringe positioning with captions noting "NO: Syringe is not pushed in far enough" and "YES: Syringe is pushed in correctly."*

FDA Label Image

E (Figure E)

An instructional illustration showing hands using a syringe-like measuring device to draw liquid from a bottle labeled 'Sodium Oxybate Oral Solution.' The plunger of the syringe is being pulled upward to measure the dosage from the bottle.*

FDA Label Image

F G (Figure F And G)

Illustration showing hands withdrawing sodium oxybate oral solution from a bottle using a measuring syringe. Enlarged insets highlight the liquid level in the syringe, indicating proper measurement between dosage marks of 1.75 g to 3.25 g with reference to air space above the liquid.*

FDA Label Image

H (Figure H)

An instructional line drawing demonstrating the use of a dosing syringe to measure and withdraw a liquid solution from a small bottle or vial, likely illustrating administration steps for sodium oxybate oral solution. One hand holds the bottle, and the other inserts the syringe into the liquid, with an arrow indicating the pulling motion to fill the syringe.*

FDA Label Image

I J (Figure I J)

An instructional diagram showing the child-resistant cap on a sodium oxybate oral solution container. On the left, hands are turning the cap down to demonstrate the child-resistant position. On the right, an image indicates not to place the cap on in a non-child-resistant position, marked with a red circle and diagonal line.*

FDA Label Image

Image 1 (Image 01)

A table listing adverse psychiatric reactions associated with sodium oxybate. Symptoms include anxiety, paranoia (feeling more suspicious), aggressive behavior, hallucinations (seeing or hearing things not real), psychosis (being out of touch with reality), and agitation.*

FDA Label Image

Image 2 (Image 02)

A list of side effects including nausea, sleepiness, dizziness, vomiting, bedwetting, and tremor. The text format appears to be a bullet-point list highlighting common adverse reactions.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure diagram of sodium oxybate showing its molecular composition with sodium ion and associated atoms and bonds as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.